Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern

被引:1
|
作者
Xiao, Yanyu [1 ]
Chen, Shengyuan [2 ]
Zhu, Yi [3 ]
McCarthy, Zachary [2 ,3 ]
Bragazzi, Nicola Luigi [2 ,3 ]
Asgary, Ali [4 ]
Wu, Jianhong [2 ,3 ]
机构
[1] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA
[2] York Univ, Dept Math & Stat, Toronto, ON, Canada
[3] York Univ, Dept Math & Stat, Lab Ind & Appl Math, Toronto, ON, Canada
[4] York Univ, Sch Adm Studies & Adv Disaster & Emergency Rapid, Disaster & Emergency Management, Toronto, ON, Canada
关键词
COVID-19; variants of concern; vaccine roll-out; optimal reopening pathway; optimization; mathematical model;
D O I
10.3389/fpubh.2021.729141
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We developed a stochastic optimization technology based on a COVID-19 transmission dynamics model to determine optimal pathways from lockdown toward reopening with different scales and speeds of mass vaccine rollout in order to maximize social economical activities while not overwhelming the health system capacity in general, hospitalization beds, and intensive care units in particular. We used the Province of Ontario, Canada as a case study to demonstrate the methodology and the optimal decision trees; but our method and algorithm are generic and can be adapted to other settings. Our model framework and optimization strategies take into account the likely range of social contacts during different phases of a gradual reopening process and consider the uncertainties of these contact rates due to variations of individual behaviors and compliance. The results show that, without a mass vaccination rollout, there would be multiple optimal pathways should this strategy be adopted right after the Province's lockdown and stay-at-home order; however, once reopening has started earlier than the timing determined in the optimal pathway, an optimal pathway with similar constraints no longer exists, and sub-optimal pathways with increased demand for intensive care units can be found, but the choice is limited and the pathway is narrow. We also simulated the situation when the reopening starts after the mass vaccination has been rolled out, and we concluded that optimal pathways toward near pre-pandemic activity level is feasible given an accelerated vaccination rollout plan, with the final activity level being determined by the vaccine coverage and the transmissibility of the dominating strain.
引用
下载
收藏
页数:10
相关论文
共 50 条
  • [41] COVID-19 and mucormycosis in Latin America - An emerging concern
    Rodriguez-Morales, Alfonso J.
    Mamani-Garcia, Carlos S.
    Nunez-Lupaca, Janeth N.
    Leon-Figueroa, Darwin A.
    Olarte-Durand, Mely
    Yrene-Cubas, Robinson A.
    Ticona, Diana M.
    Abanto-Urbano, Sebastian
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 44
  • [42] COVID-19: From emerging variants to vaccination
    Senevirathne, Thilini H.
    Wekking, Demi
    Swain, Joseph W. R.
    Solinas, Cinzia
    De Silva, Pushpamali
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 76 : 127 - 141
  • [43] Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
    Haque, Azizul
    Pant, Anudeep B.
    JOURNAL OF AUTOIMMUNITY, 2022, 127
  • [44] COVID-19 vaccine wastage in Canada, a reason for concern?
    Aubrey, Lauren
    Ishak, Angela
    Dutta, Shubham
    Rajesh, Eshwar
    Suvvari, Tarun Kumar
    Mukherjee, Dattatreya
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2022, 113 (02): : 209 - 210
  • [45] COVID-19 vaccine wastage in Canada, a reason for concern?
    Lauren Aubrey
    Angela Ishak
    Shubham Dutta
    Eshwar Rajesh
    Tarun Kumar Suvvari
    Dattatreya Mukherjee
    Canadian Journal of Public Health, 2022, 113 : 209 - 210
  • [46] Role of vaccine in fighting the variants of COVID-19
    Wang, Jian
    Jiang, Wenjing
    Wu, Xinpei
    Yang, Mengdie
    Shao, Wei
    CHAOS SOLITONS & FRACTALS, 2023, 168
  • [47] COVID-19 double whammy - Vaccine and variants
    Woodcock, Barrington G.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (04) : 267 - 268
  • [48] Modeling optimal reopening strategies for COVID-19 and its variants by keeping infections low and fixing testing capacity
    Dalton, Mackenzie
    Dougall, Paul
    Darko, Frederick Laud Amoah
    Annan, William
    Asante-Asamani, Emmanuel
    Bailey, Susan
    Greene, James
    White, Diana
    PLOS ONE, 2022, 17 (11):
  • [49] Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern
    Islam, Khursheed Ul
    A-Elgadir, Thoraya Mohamed Elhassan
    Afaq, Sarah
    Ahmad, Tanveer
    Iqbal, Jawed
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] COVID-19 Vaccine Tweets After Vaccine Rollout: Sentiment-Based Topic Modeling
    Huangfu, Luwen
    Mo, Yiwen
    Zhang, Peijie
    Zeng, Daniel Dajun
    He, Saike
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (02)